143
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

, , , , , & show all
Pages 1527-1533 | Published online: 13 Jun 2018

References

  • NathanDMLong-term complications of diabetes mellitusN Engl J Med199332823167616858487827
  • EkePIWeiLThornton-EvansGORisk indicators for periodontitis in US adults: NHANES 2009 to 2012J Periodontol201687101174118527367420
  • ChenJZhengPLiuYSex differences in gut microbiota in patients with major depressive disorderNeuropsychiatr Dis Treat20181464765529520144
  • ChenJJZhouCJZhengPDifferential urinary metabolites related with the severity of major depressive disorderBehav Brain Res201733228028728624318
  • ChenJJZengBHLiWWEffects of gut microbiota on the microRNA and mRNA expression in the hippocampus of miceBehav Brain Res2017322Pt A344128093256
  • GoldenSHLazoMCarnethonMExamining a bidirectional association between depressive symptoms and diabetesJAMA2008299232751275918560002
  • EiberRBerlinIGrimaldiABisserbeJCInsulin-dependent diabetes and psychiatric pathology: general clinical and epidemiologic reviewEncephale1997231351357 In French9453927
  • AgiusAXuerebRBCarrick-SenDSultanaRRankinJThe coexistence of depression, anxiety and post-traumatic stress symptoms in the perinatal period: a systematic reviewMidwifery201636707927106946
  • RoglicGUnwinNMortality attributable to diabetes: estimates for the year 2010Diabetes Res Clin Pract2010871151919914728
  • WolfNJHopkoDRPsychosocial and pharmacological interventions for depressed adults in primary care: a critical reviewClin Psychol Rev200828113116117555857
  • RabkinJQutkinFHarrisonWTricamoEMcGrathPAdverse reactions to monoamine oxidase inhibitors. I. A comparative studyJ Clin Psychopharmacol1984452702786386898
  • HindmarchIThe psychopharmacological approach: effects of psychotropic drugs on car handlingInt Clin Psychopharmacol19883Suppl 173793403952
  • GehlawatPGuptaRRajputRGahlanDGehlawatVKDiabetes with comorbid depression: role of SSRI in better glycemic controlAsian J Psychiatr20136536436824011681
  • GoodnickPJUse of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathyAnn Clin Psychiatry2001131314111465683
  • LustmanPJFreedlandKEGriffithLSClouseREFluoxetine for depression in diabetes: a randomized, double-blind, placebo-controlled trialDiabetes Care200023561862310834419
  • GülserenLGülserenSHekimsoyZMeteLComparison of fluoxetine and paroxetine in type II diabetes mellitus patientsArch Med Res200536215916515847950
  • Potter van LoonBJRadderJKFrolichMKransHMZwindermanAHMeindersAEFluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patientsInt J Obes Relat Metab Disord199216Suppl 4S55S611338387
  • KaraiskosDTzavellasEIliasILiappasIPaparrigopoulosTAgomelatine and sertraline for the treatment of depression in type 2 diabetes mellitusInt J Clin Pract201367325726023409693
  • ChenJWXieSQAgomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney diseaseNeuropsychiatr Dis Treat20181454755229497298
  • KangRHeYYanYComparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trialNeuropsychiatr Dis Treat2015111307131126064049
  • KentJMDalyEKezicIEfficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depressionProgr Neuropsychopharmacol Biol Psychiatry2016676673
  • ChiltonRTikkanenICannonCPEffects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetesDiabetes Obes Metab201517121180119326343814
  • JamiesonJAnalysis of covariance (ANCOVA) with difference scoresInt J Psychophysiol200452327728315094250
  • DaubresseJCKolanowskiJKrzentowskiGKutnowskiMScheenAVan GaalLUsefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter studyObes Res1996443913968822764
  • ConnollyVMGallagherAKessonCMA study of fluoxetine in obese elderly patients with type 2 diabetesDiabet Med19951254164187648804
  • KasperSHajakGWulffKEfficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertralineJ Clin Psychiatry201071210912020193645
  • SinghSPSingVKarNEffcacy of agomelatine in major depressive disorder: meta-analysis and appraisalInt J Neuropsychopharmacol201215341742821859514
  • TaylorDSparshattAVarmaSOlofinjanaOAntidepressant efficacy of agomelatine: meta-analysis of published and unpublished studiesBMJ2014348g188824647162
  • AydınEGüleçMOralEDaloğluAGAgomelatine vs fluoxetine: efficacy and improvement of cognitive functions in patients with MDDEur Psychiatry201633SupplS501S502
  • TamuraYTanakaYSatoFEffects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patientsJ Clin Endocrinol Metab20059063191319615769987